On a consolidated basis, Max Healthcare Institutes net profit rose 77.54% to Rs 123.73 crore on 17.08% rise in net sales to Rs 938.80 crore in Q4 March 2022 over Q4 March 2021.
Sales rise 38.27% to Rs 568.81 crore
Sales rise 38.27% to Rs 568.81 crore
Sales decline 9.82% to Rs 151.61 crore
Sales decline 30.34% to Rs 323.08 crore
EBITDA for FY22 stood at Rs361.60 crore, registering a growth of 20% yoy against Rs301.30 crore in the previous financial year.
Sales rise 500.00% to Rs 0.06 crore
Sales rise 19.05% to Rs 50.44 crore
Sales decline 68.09% to Rs 0.82 crore
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
